| Endosomal escape pathways for delivery of biologicals AK Varkouhi, M Scholte, G Storm, HJ Haisma Journal of Controlled Release 151 (3), 220-228, 2011 | 1700 | 2011 |
| Histone acetyl transferases as emerging drug targets FJ Dekker, HJ Haisma Drug discovery today 14 (19-20), 942-948, 2009 | 372 | 2009 |
| Tauroursodeoxycholic acid protects rat hepatocytes from bile acid‐induced apoptosis via activation of survival pathways MH Schoemaker, L Conde de la Rosa, M Buist‐Homan, TE Vrenken, ... Hepatology 39 (6), 1563-1573, 2004 | 204 | 2004 |
| Beta-glucuronidase-mediated drug release M Graaf, E Boven, HW Scheeren, HJ Haisma, HM Pinedo Current pharmaceutical design 8 (15), 1391-1403, 2002 | 199 | 2002 |
| Stem cell injections in knee osteoarthritis: a systematic review of the literature HI Pas, M Winters, HJ Haisma, MJJ Koenis, JL Tol, MH Moen British journal of sports medicine 51 (15), 1125-1133, 2017 | 190 | 2017 |
| Targeting of adenoviral vectors through a bispecific single-chain antibody HJ Haisma, J Grill, DT Curiel, S Hoogeland, VW Van Beusechem, ... Cancer gene therapy 7 (6), 901-904, 2000 | 190 | 2000 |
| A Novel Strategy to Modify Adenovirus Tropism and Enhance Transgene Delivery to Activated Vascular Endothelial Cells In Vitro and In Vivo K Ogawara, MG Rots, RJ Kok, HE Moorlag, AM Van Loenen, DKF Meijer, ... Human gene therapy 15 (5), 433-443, 2004 | 177 | 2004 |
| Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation T Karpanen, M Wirzenius, T Mäkinen, T Veikkola, HJ Haisma, MG Achen, ... The American journal of pathology 169 (2), 708-718, 2006 | 172 | 2006 |
| Gene doping HJ Haisma, O de Hon International journal of sports medicine 27 (04), 257-266, 2006 | 170 | 2006 |
| Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation M Ghizzoni, HJ Haisma, H Maarsingh, FJ Dekker Drug discovery today 16 (11-12), 504-511, 2011 | 169 | 2011 |
| Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation MH Schoemaker, WM Gommans, LC de la Rosa, M Homan, P Klok, ... Journal of hepatology 39 (2), 153-161, 2003 | 164 | 2003 |
| Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89 WE Meijs, JDM Herscheid, HJ Haisma, HM Pinedo International journal of radiation applications and instrumentation. Part A …, 1992 | 163 | 1992 |
| Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids J Grill, VW Van Beusechem, P Van Der Valk, CMF Dirven, A Leonhart, ... Clinical cancer research 7 (3), 641-650, 2001 | 160 | 2001 |
| Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM HJ Haisma, HM Pinedo, A Van Rijswijk, I Van Der Meulen-Muileman, ... Gene therapy 6 (8), 1469-1474, 1999 | 156 | 1999 |
| 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site M Ghizzoni, J Wu, T Gao, HJ Haisma, FJ Dekker, YG Zheng European journal of medicinal chemistry 47, 337-344, 2012 | 141 | 2012 |
| Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice WE Meijs, HJ Haisma, RP Klok, FB Van Gog, E Kievit, HM Pinedo, ... Journal of Nuclear Medicine 38 (1), 112-118, 1997 | 136 | 1997 |
| A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer HJ Haisma, E Boven, M Van Muijen, J De Jong, WJF Van der Vijgh, ... British journal of cancer 66 (3), 474-478, 1992 | 130 | 1992 |
| Production of highly pure no-carrier added 89Zr for the labelling of antibodies with a positron emitter WE Meijs, JDM Herscheid, HJ Haisma, R Wijbrandts, F van Langevelde, ... Applied radiation and isotopes 45 (12), 1143-1147, 1994 | 126 | 1994 |
| Therapeutic modulation of endogenous gene function by agents with designed DNA‐sequence specificities TG Uil, HJ Haisma, MG Rots Nucleic acids research 31 (21), 6064-6078, 2003 | 123 | 2003 |
| HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 … NGJ Leus, PE van der Wouden, T van den Bosch, WTR Hooghiemstra, ... Biochemical pharmacology 108, 58-74, 2016 | 120 | 2016 |
Marianne G Rotshoogleraar Moleculaire Epigenetica在 umcg.nl 的电子邮件经过验证
